KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Inventory (2016 - 2025)

Historic Inventory for Bausch Health Companies (BHC) over the last 17 years, with Q3 2025 value amounting to $1.6 billion.

  • Bausch Health Companies' Inventory fell 344.41% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year decrease of 344.41%. This contributed to the annual value of $1.6 billion for FY2024, which is 330.31% up from last year.
  • As of Q3 2025, Bausch Health Companies' Inventory stood at $1.6 billion, which was down 344.41% from $1.7 billion recorded in Q2 2025.
  • In the past 5 years, Bausch Health Companies' Inventory ranged from a high of $1.7 billion in Q3 2024 and a low of $993.0 million during Q4 2021
  • Its 5-year average for Inventory is $1.3 billion, with a median of $1.2 billion in 2023.
  • Per our database at Business Quant, Bausch Health Companies' Inventory tumbled by 1356.21% in 2021 and then soared by 4165.14% in 2023.
  • Over the past 5 years, Bausch Health Companies' Inventory (Quarter) stood at $993.0 million in 2021, then grew by 9.77% to $1.1 billion in 2022, then surged by 41.65% to $1.5 billion in 2023, then grew by 3.3% to $1.6 billion in 2024, then grew by 0.19% to $1.6 billion in 2025.
  • Its Inventory was $1.6 billion in Q3 2025, compared to $1.7 billion in Q2 2025 and $1.6 billion in Q1 2025.